values for levofloxacin Search Results


mic values against levofloxacin  (ATCC)
99
ATCC mic values against levofloxacin
In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of <t>MIC</t> values against <t>levofloxacin</t> of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control
Mic Values Against Levofloxacin, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mic values against levofloxacin/product/ATCC
Average 99 stars, based on 1 article reviews
mic values against levofloxacin - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
results ampicillin piperacillin teicoplanin ciprofloxacin levofloxacin meropenem erythromycin e coli  (ATCC)
99
ATCC results ampicillin piperacillin teicoplanin ciprofloxacin levofloxacin meropenem erythromycin e coli
In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of <t>MIC</t> values against <t>levofloxacin</t> of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control
Results Ampicillin Piperacillin Teicoplanin Ciprofloxacin Levofloxacin Meropenem Erythromycin E Coli, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/results ampicillin piperacillin teicoplanin ciprofloxacin levofloxacin meropenem erythromycin e coli/product/ATCC
Average 99 stars, based on 1 article reviews
results ampicillin piperacillin teicoplanin ciprofloxacin levofloxacin meropenem erythromycin e coli - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
values for levofloxacin  (ATCC)
90
ATCC values for levofloxacin
In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of <t>MIC</t> values against <t>levofloxacin</t> of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control
Values For Levofloxacin, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/values for levofloxacin/product/ATCC
Average 90 stars, based on 1 article reviews
values for levofloxacin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
levofloxacin  (Millipore)
90
Millipore levofloxacin
In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of <t>MIC</t> values against <t>levofloxacin</t> of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control
Levofloxacin, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/levofloxacin/product/Millipore
Average 90 stars, based on 1 article reviews
levofloxacin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
moxifloxacin (mxf)  (Thermo Fisher)
90
Thermo Fisher moxifloxacin (mxf)
In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of <t>MIC</t> values against <t>levofloxacin</t> of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control
Moxifloxacin (Mxf), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/moxifloxacin (mxf)/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
moxifloxacin (mxf) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
levofloxacin m i c evaluator strips m i c e  (Thermo Fisher)
N/A
Effortlessly establish accurate Minimum Inhibitory Concentration MIC values manually using Thermo Scientific Oxoid Levofloxacin M I C Evaluator Strips M I C E
   Buy from Supplier

Image Search Results


In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of MIC values against levofloxacin of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control

Journal: Chinese Medicine

Article Title: Quinic acid: a potential antibiofilm agent against clinical resistant Pseudomonas aeruginosa

doi: 10.1186/s13020-021-00481-8

Figure Lengend Snippet: In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of MIC values against levofloxacin of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC. *P < 0.05, compared with corresponding control

Article Snippet: Fig. 1 In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of MIC values against levofloxacin of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC.

Techniques: In Vitro, Control

Active antibiofilm compounds from metabolites of CA in LJF. a Antibiofilm activity of LJF and CA. b Growth curves of bacterial growth at different sub-MICs of CA. c GC–MS analysis of CA at 0.5, 1, 2, 4, 6, 24 h. The red arrow indicates the location of the peak of CA. d Measured ion spectrum (upper) and matched ion spectrum in NIST17 database (lower) of CA. e Metabolic pathways of CA in intestine (left) and liver (right). f In vitro antibiofilm effects of CA and its intestinal metabolites. g In vitro antibiofilm effects of CA and its liver metabolites. h GC–MS analysis of quinic acid at 0.5, 1, 2, 4, 6, 24 h. The red arrow indicates the location of the peak of quinic acid. i Measured ion spectrum (upper) and matched ion spectrum in NIST17 database (lower) of quinic acid. j The antibacterial activity ratio of caffeic acid and quinic acid to CA. k The antibacterial activity ratio of caffeic acid and its main metabolites to CA. l , m The antibacterial activity ratio of quinic acid and its major metabolites to CA. n – o Effects of dihydrocaffeic acid and gallic acid on the integrity (n) and the permeability (o) of bacteria membrane against MRSA. p - q Effects of dihydrocaffeic acid on the integrity ( p ) and the permeability ( q ) of bacteria membrane against MSSA. r Effects of quinic acid on EPS secretion in biofilm formation (upper) and in mature biofilm (lower). s – u The synergistic antibiofilm effects of sub-MIC quinic acid with levofloxacin ( s ), clarithromycin ( t ) and azithromycin ( v ). QA: quinic acid. *P < 0.05, **P < 0.01, compared with corresponding control

Journal: Chinese Medicine

Article Title: Quinic acid: a potential antibiofilm agent against clinical resistant Pseudomonas aeruginosa

doi: 10.1186/s13020-021-00481-8

Figure Lengend Snippet: Active antibiofilm compounds from metabolites of CA in LJF. a Antibiofilm activity of LJF and CA. b Growth curves of bacterial growth at different sub-MICs of CA. c GC–MS analysis of CA at 0.5, 1, 2, 4, 6, 24 h. The red arrow indicates the location of the peak of CA. d Measured ion spectrum (upper) and matched ion spectrum in NIST17 database (lower) of CA. e Metabolic pathways of CA in intestine (left) and liver (right). f In vitro antibiofilm effects of CA and its intestinal metabolites. g In vitro antibiofilm effects of CA and its liver metabolites. h GC–MS analysis of quinic acid at 0.5, 1, 2, 4, 6, 24 h. The red arrow indicates the location of the peak of quinic acid. i Measured ion spectrum (upper) and matched ion spectrum in NIST17 database (lower) of quinic acid. j The antibacterial activity ratio of caffeic acid and quinic acid to CA. k The antibacterial activity ratio of caffeic acid and its main metabolites to CA. l , m The antibacterial activity ratio of quinic acid and its major metabolites to CA. n – o Effects of dihydrocaffeic acid and gallic acid on the integrity (n) and the permeability (o) of bacteria membrane against MRSA. p - q Effects of dihydrocaffeic acid on the integrity ( p ) and the permeability ( q ) of bacteria membrane against MSSA. r Effects of quinic acid on EPS secretion in biofilm formation (upper) and in mature biofilm (lower). s – u The synergistic antibiofilm effects of sub-MIC quinic acid with levofloxacin ( s ), clarithromycin ( t ) and azithromycin ( v ). QA: quinic acid. *P < 0.05, **P < 0.01, compared with corresponding control

Article Snippet: Fig. 1 In vitro screening of 13 plant extracts with antibiofilm activities against clinical resistant isolates of PA. a The distribution of MIC values against levofloxacin of 96 clinical isolates of PA. b The level of biofilm formation in 12 resistant strains of PA. c The MIC values of 13 plant extracts against PA1803 and ATCC 27853. d The antibiofilm activities of 13 plant extracts against PA1803 at MIC and 1/2MIC.

Techniques: Activity Assay, Gas Chromatography-Mass Spectrometry, In Vitro, Permeability, Bacteria, Membrane, Control